Lyon Street Capital LLC trimmed its holdings in shares of Cutera, Inc. (NASDAQ:CUTR) by 76.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 83,506 shares of the medical device company’s stock after selling 276,888 shares during the period. Lyon Street Capital LLC owned 0.60% of Cutera worth $3,453,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Legal & General Group Plc raised its holdings in shares of Cutera by 69.6% during the third quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock worth $149,000 after purchasing an additional 1,477 shares during the period. Greenwood Capital Associates LLC acquired a new stake in shares of Cutera in the 3rd quarter worth about $210,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Cutera in the 3rd quarter worth about $264,000. Mackenzie Financial Corp acquired a new stake in shares of Cutera in the 3rd quarter worth about $277,000. Finally, Nationwide Fund Advisors increased its holdings in shares of Cutera by 8.4% in the 2nd quarter. Nationwide Fund Advisors now owns 7,216 shares of the medical device company’s stock worth $187,000 after acquiring an additional 561 shares during the period. 87.64% of the stock is currently owned by institutional investors.
A number of analysts recently weighed in on CUTR shares. TheStreet raised shares of Cutera from a “c” rating to a “b” rating in a report on Friday, August 18th. BidaskClub raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Saturday, August 12th. Gabelli reaffirmed a “buy” rating on shares of Cutera in a report on Wednesday, August 9th. Roth Capital increased their price objective on shares of Cutera from $32.00 to $39.00 and gave the stock a “buy” rating in a report on Tuesday, August 8th. Finally, Maxim Group reaffirmed a “hold” rating on shares of Cutera in a report on Wednesday, November 8th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Cutera currently has a consensus rating of “Buy” and an average price target of $37.33.
Cutera (NASDAQ:CUTR) last released its earnings results on Tuesday, November 7th. The medical device company reported $0.42 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.08 by $0.34. The firm had revenue of $38.17 million for the quarter, compared to analysts’ expectations of $34.82 million. Cutera had a net margin of 7.99% and a return on equity of 18.73%. Cutera’s quarterly revenue was up 26.1% on a year-over-year basis. During the same quarter last year, the company earned $0.12 EPS. research analysts predict that Cutera, Inc. will post 0.55 earnings per share for the current year.
In other Cutera news, Director David B. Apfelberg sold 1,000 shares of the firm’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $38.45, for a total transaction of $38,450.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Larry Laber sold 1,250 shares of the firm’s stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $44.30, for a total transaction of $55,375.00. Following the transaction, the executive vice president now directly owns 70,463 shares in the company, valued at approximately $3,121,510.90. The disclosure for this sale can be found here. In the last three months, insiders have sold 20,725 shares of company stock worth $843,253. 3.30% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION WARNING: “Lyon Street Capital LLC Reduces Holdings in Cutera, Inc. (CUTR)” was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.chaffeybreeze.com/2017/12/06/lyon-street-capital-llc-reduces-holdings-in-cutera-inc-cutr.html.
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.